Cardiome Pharma Corp.

Cardiome Pharma Corp.

Cardiome Pharma Corp. was founded in 1986 and is headquartered in Vancouver, Canada. Cardiome Pharma Corp., a life sciences company, focuses on developing drugs to treat or prevent cardiovascular diseases. Its product Vernakalant (iv), which has completed Phase III (ACT 4) and in Phase III (European Comparator) trial is used for the treatment of atrial fibrillation; Vernakalant (oral) that has completed Phase IIa Pilot and Phase IIb study is used for atrial fibrillation; GED-aPC, an ongoing Phase I study product for multiple disease states; and Artesian Programs, which is in pre-clinical studies to attenuate the deleterious effects of the excessive neurohormonal activation that occurs in diseases of cardiac dysfunction.

Contact Details

Office Address

Cardiome Pharma Corp.
6190 Agronomy Rd., 6th Floor
Vancouver, B.C., Canada V6T1Z3
Phone: (604) 677-6905
Fax: (604) 677-6915


Exec. Chairman

Mr. Robert Rieder

Chief Exec. Officer

Mr. Douglas G. Janzen

Business Reviews for Cardiome Pharma Corp.

Related Companies